Evidence map›Paper›PMID 42015161›Full record

ArticleJournal of nanobiotechnology2026

Beyond one-size-fits-all: cancer biology shapes nanoparticle behavior.

Maria Bravo, Guillermo Solís-Fernandez, Sandra Krzyzowska, Steven Huysecom, Ana Montero-Calle, Indra Van Zundert, Boris Louis, James Hutchison, Rodrigo Barderas, Beatrice Fortuni and 1 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maria BravoMolecular Imaging and Photonics, Chemistry Department, KU Leuven, Celestijnenlaan 200F, Heverlee, 3001, Belgium.
Guillermo Solís-FernandezMolecular Imaging and Photonics, Chemistry Department, KU Leuven, Celestijnenlaan 200F, Heverlee, 3001, Belgium. guillermo.solisfernandez@kuleuven.be.
Sandra KrzyzowskaMolecular Imaging and Photonics, Chemistry Department, KU Leuven, Celestijnenlaan 200F, Heverlee, 3001, Belgium.
Steven HuysecomMolecular Imaging and Photonics, Chemistry Department, KU Leuven, Celestijnenlaan 200F, Heverlee, 3001, Belgium.
Ana Montero-CalleFunctional Proteomics Unit, Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, E-28220, Madrid, Spain.
Indra Van ZundertMolecular Imaging and Photonics, Chemistry Department, KU Leuven, Celestijnenlaan 200F, Heverlee, 3001, Belgium.
Boris LouisMolecular Imaging and Photonics, Chemistry Department, KU Leuven, Celestijnenlaan 200F, Heverlee, 3001, Belgium.
James HutchisonARC Centre of Excellence in Exciton Science, School of Chemistry, University of Melbourne, Parkville, VIC, 3010, Australia.
Rodrigo BarderasFunctional Proteomics Unit, Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, E-28220, Madrid, Spain.
Beatrice FortuniMolecular Imaging and Photonics, Chemistry Department, KU Leuven, Celestijnenlaan 200F, Heverlee, 3001, Belgium. beatrice.fortuni@kuleuven.be.
Susana RochaMolecular Imaging and Photonics, Chemistry Department, KU Leuven, Celestijnenlaan 200F, Heverlee, 3001, Belgium. susana.rocha@kuleuven.be.

Funding

AES-ISCIII program cofounded by FEDER funds PI20CIII/00019 and PI23CIII/00027Global PhD partnership program between KU Leuven and Melbourne University GPUM/21/025KU Leuven IDN/20/021, C14/15/053, C14/19/079, and C14/22/085Research Foundation of Flanders (FWO) 11A0S25NResearch Foundation of Flanders (FWO) 12A6N25NResearch Foundation of Flanders (FWO) 12AGZ24NResearch Foundation of Flanders (FWO) 12AML24NResearch Foundation of Flanders (FWO) G022724N, 12X1419N, 12X1423NResearch Foundation of Flanders (FWO) G0D4519N, G081916N, VS08523N, G0C1821N
6 · The paper itself

Abstract

Nanoparticles (NPs) are a promising tool for cancer therapy, yet few have successfully reached clinical application. Current nanomedicine development pipelines are focused on optimizing the physical properties of NPs, overlooking the impact of cancer biology on their behavior. Here, we show that the polyethyleneimine-functionalized, silica-coated gold NPs (Au@mSi-PEI) exhibit distinct accumulation and penetration patterns in 3D spheroids derived from four spheroid models (representative of lung, colon, breast, and cervical cancer). We uncover an inverse relationship between NP uptake and penetration: spheroids with slower internalization show deeper NP diffusion. Proteomic analysis revealed that tumor-specific expression of endocytic and extracellular matrix proteins underlies this variability. Our findings challenge the prevailing 'one-size-fits-all' approach and highlight the need to integrate cancer biology into NP design. Tailoring NPs to the unique cellular and extracellular features of each tumor type will be critical for developing more effective and clinically relevant nanotherapies.

Indexed as

Metal NanoparticlesNanoparticlesNeoplasmsCell Line, TumorGoldHumansPolyethyleneimineSilicon DioxideSpheroids, CellularGoldPolyethyleneimineSilicon Dioxide3D cell modelsCancer spheroidsECM compositionEndosomal traffickingNanoparticle cellular uptakeNanoparticles

Identifiers

PMID42015161
PMCPMC13244900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.